中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [8]
化学研究所 [4]
水土保持研究所 [3]
合肥物质科学研究院 [3]
金属研究所 [2]
国家天文台 [2]
更多
采集方式
OAI收割 [38]
内容类型
期刊论文 [37]
专利 [1]
发表日期
2025 [2]
2024 [3]
2023 [2]
2021 [5]
2020 [1]
2018 [2]
更多
学科主题
Agricultur... [1]
Environmen... [1]
Geology; M... [1]
Science & ... [1]
物理化学 [1]
生物材料 [1]
更多
筛选
浏览/检索结果:
共38条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
发表日期升序
发表日期降序
题名升序
题名降序
提交时间升序
提交时间降序
Fibroblast activation protein peptide-targeted NIR-I/II fluorescence imaging for stable and functional detection of hepatocellular carcinoma
期刊论文
OAI收割
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 页码: 14
作者:
Lin, En
;
Song, Miaomiao
;
Wang, Bo
;
Shi, Xiaojing
;
Zhao, Jiali
  |  
收藏
  |  
浏览/下载:48/0
  |  
提交时间:2025/04/01
Hepatocellular carcinoma
Cancer-associated fibroblasts
Fibroblast activation protein
Near-infrared fluorescence
Peptide-targeted fluorescence imaging
Transcriptome Analysis Provides New Insights into Bulbil Formation in Bistorta vivipara
期刊论文
OAI收割
PHYTON-INTERNATIONAL JOURNAL OF EXPERIMENTAL BOTANY, 2025
作者:
Zhao, Weimin
;
Shi, Guomin
;
Guo, Jialei
;
He, Guifang
;
Li, Peilan
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2025/11/27
Bistorta vivipara
vegetative organ vivipary
bulbil
transcriptome analysis
Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial
期刊论文
OAI收割
ECLINICALMEDICINE, 2024, 卷号: 76
作者:
Yan, Min
;
Ouyang, Quchang
;
Sun, Tao
;
Niu, Limin
;
Yang, Jin
  |  
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2024/11/20
Pyrotinib
Human epidermal growth factor receptor 2
Breast cancer
Brain metastases
Overall survival
Structure-based development of potent and selective type-II kinase inhibitors of RIPK1
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2024, 卷号: 14, 期号: 1, 页码: 319-334
作者:
Qin, Ying
;
Li, Dekang
;
Qi, Chunting
;
Xiang, Huaijiang
;
Meng, Huyan
  |  
收藏
  |  
浏览/下载:69/0
  |  
提交时间:2024/03/06
RIPK1
Necroptosis
Type-II kinase inhibitors
Rational design
Lead optimization
Structure-activity relationship
Anti-inflammation
Preclinical drug discovery
SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3/CCL2/IL-6 axis and is regulated by VEZF1
期刊论文
OAI收割
THERANOSTICS, 2024, 卷号: 14, 期号: 17, 页码: 6543-6559
作者:
Li, Meiqian
;
Cui, Yangyan
;
Qi, Qi
;
Liu, Jiakuan
;
Li, Jiaxuan
  |  
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2024/12/25
SPOP
bladder cancer
tumor-associated macrophage
STAT3/CCL2/IL-6 axis
VEZF1
Effects of upslope inflow rate, tillage depth, and slope gradients on hillslope erosion processes and hydrodynamic mechanisms
期刊论文
OAI收割
CATENA, 2023, 卷号: 228, 页码: 14
作者:
Zhao, Luyou
;
Qin, Qishan
;
Geng, Huajie
;
Zheng, Fenli
;
Zhang, Xunchang J.
  |  
收藏
  |  
浏览/下载:61/0
  |  
提交时间:2023/10/09
Dimensionless hydrodynamic parameter
Inflow rate
Slope gradient
Soil erosion rates
Tillage depth
Research progress on the analysis and application of radioactive hot particle
期刊论文
OAI收割
JOURNAL OF ENVIRONMENTAL RADIOACTIVITY, 2023, 期号: 270, 页码: 107313
作者:
Zhao, Guifang
;
Shao, Yang
;
Luo, Min
;
Xu, Diandou
;
Li, Duohong
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2026/03/17
Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 19, 页码: 14822-14847
作者:
Wei, Dan
;
Wang, Hanlin
;
Zeng, Qinghe
;
Wang, Wenjing
;
Hao, Bingbing
  |  
收藏
  |  
浏览/下载:76/0
  |  
提交时间:2021/12/16
Kynurenine derivative 3-HAA is an agonist ligand for transcription factor YY1
期刊论文
OAI收割
Journal of Hematology & Oncology, 2021, 卷号: 14, 期号: 1
作者:
Shi,Zhaopeng
;
Gan,Guifang
;
Xu,Xiang
;
Zhang,Jieying
;
Yuan,Yuan
  |  
收藏
  |  
浏览/下载:93/0
  |  
提交时间:2021/11/04
3-Hydroxyanthronic acid (3-HAA)
Kynurenine
YY1
DUSP6
Hepatocellular carcinoma (HCC)
Tryptophan metabolism
Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.
期刊论文
OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Li, Jin
;
Qin, Shukui
;
Wen, Lu
;
Wang, Junsheng
;
Deng, Wenying
  |  
收藏
  |  
浏览/下载:61/0
  |  
提交时间:2022/01/10